An AI-Powered Tool to Identify and Assess Fit-for-Use Registries for Drug Development and Evaluation
Event: ISPOR Europe 2025, Glasgow, Scotland, UK Authors: Ghinwa Y. Hayek, Boris Kopin, Sonia Zebachi, Gaëtan Pinon, Basile Ferry, Elisabeth Bakker, Alexandre Macquin, Sieta T. de Vries, Peter G.M. Mol, Billy Amzal View Poster OBJECTIVES Selecting appropriate real-world data (RWD) sources, particularly registries, is a primary challenge for academia, industry, regulators, and health technology assessment (HTA) […]
An AI powered tool to identify and assess fit-for use registries for real-world evidence
Event: EuroDURG 2025, Uppsala, Sweden Authors: Ghinwa Y. Hayek, Pascal Godbillot, Coriande Clemente, Sonia Zebachi, Gaëtan Pinon, Boris Kopin, Elisabeth Bakker, Sieta T. de Vries, Peter G.M. Mol, Billy Amzal View publication Abstract The selection of appropriate real-world data (RWD) sources, particularly registries, is of primary concern for academia, industry, regulators, and health technology assessment […]
Existing automated tools to assist evidence generation and better qualification of registries and real-world data. A systematic review from the More-EUROPA project
Event: ISPOR Europe 2023, Copenhagen, Denmark Authors: P. Godbillot, P. Tang, J. Moreira, J. Tanniou S. Zebachi, B. Amzal View Poster Objectives The More-EUROPA project consortium brings together 14 public and private entities from 7 countries with the aim of enhancing the ethical and effective utilization of registry data to facilitate patient-centered decision-making by drug regulators and Health Technology Assessment […]
A machine learning algorithm to identify persons at risk of Gaucher disease using EHR in the United States
Gaucher disease is a rare inherited lysosomal storage disorder (LSD) which mainly leads to hepatosplenomegaly, anemia, thrombocytopenia, bone lesions/symptoms, and neurological impairment. Its progressive clinical manifestations are often highly debilitating, shorten lifespans and are considerably variable.
Alexandre Templier will speak at the Real-World Evidence and Market Access Conference
Quinten Health will be at the Real-World Evidence and Market Access Conference in Frankfurt, Germany. Alexandre Templier (President)will attend as a speaker the Real-World Evidence and Market Access Conference – EU Edition. In this session, he will unveil next-generation disease and care models, powered by artificial intelligence, to support drug clinical development, market access and life […]
